{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:48:10Z","timestamp":1784958490396,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03692-7","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:39:44Z","timestamp":1740062384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuchu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"18","key":"3692_CR1","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.3748\/wjg.v20.i18.5191","volume":"20","author":"DY Graham","year":"2014","unstructured":"Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20(18):5191\u2013204.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3692_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report. Gut. 2017;66(1):6\u201330.","journal-title":"Gut"},{"issue":"1","key":"3692_CR3","first-page":"79","volume":"45","author":"L Gu","year":"2020","unstructured":"Gu L, Yang H. Factors associated with failure of Helicobacter pylori eradication. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(1):79\u201384.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"3692_CR4","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.2147\/IDR.S358464","volume":"15","author":"QL Lan","year":"2022","unstructured":"Lan QL, Sun HY, Ye Y, Wang Y, Liu Y, Weng XJ. Factors Affect the Eradication Rate of Helicobacter pylori by Modified Quadruple Therapy: A Prospective Cohort Study. Infect Drug Resist. 2022;15:2339\u201345.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3692_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12178","volume":"20","author":"C Xie","year":"2015","unstructured":"Xie C, Lu NH. Review: clinical management of Helicobacter pylori infection in China. Helicobacter. 2015;20(1):1\u201310.","journal-title":"Helicobacter"},{"issue":"2","key":"3692_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cmi.2019.06.007","volume":"26","author":"B Bluemel","year":"2020","unstructured":"Bluemel B, Goelz H, Goldmann B, Gr\u00fcger J, Hamel H, Loley K, et al. Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018. Clin Microbiol Infect. 2020;26(2):235\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"3692_CR7","first-page":"5027","volume":"11","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, Zhang Z, Wang J, Hu Y, Mi Y, He B, et al. A retrospective study of the antibiotic-resistant phenotypes and genotypes of Helicobacter pylori strains in China. Am J Cancer Res. 2021;11(10):5027\u201337.","journal-title":"Am J Cancer Res"},{"issue":"9","key":"3692_CR8","doi-asserted-by":"publisher","first-page":"e0309844","DOI":"10.1371\/journal.pone.0309844","volume":"19","author":"Z Xue","year":"2024","unstructured":"Xue Z, Li W, Ding H, Pei F, Zhang J, Gong Y, et al. Virulence gene polymorphisms in Shandong Helicobacter pylori strains and their relevance to gastric cancer. PLoS ONE. 2024;19(9):e0309844.","journal-title":"PLoS ONE"},{"issue":"3","key":"3692_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jgh.15751","volume":"37","author":"S Ren","year":"2022","unstructured":"Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(3):464\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"3692_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3692_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/antibiotics12020332","volume":"12","author":"L Boyanova","year":"2023","unstructured":"Boyanova L, Hadzhiyski P, Gergova R, Markovska R. Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern. Antibiotics (Basel). 2023;12(2):332.","journal-title":"Antibiotics (Basel)."},{"issue":"6","key":"3692_CR12","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/jac\/dkz046","volume":"74","author":"WC Tai","year":"2019","unstructured":"Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, et al. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial. J Antimicrob Chemother. 2019;74(6):1718\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3692_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12762","volume":"25","author":"Z Song","year":"2020","unstructured":"Song Z, Zhou L, Xue Y, Suo B, Tian X, Niu Z. A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial. Helicobacter. 2020;25(6): e12762.","journal-title":"Helicobacter"},{"issue":"3","key":"3692_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.14309\/ajg.0000000000000132","volume":"114","author":"J Yang","year":"2019","unstructured":"Yang J, Zhang Y, Fan L, Zhu YJ, Wang TY, Wang XW, et al. Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori. Am J Gastroenterol. 2019;114(3):437\u201345.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3692_CR15","doi-asserted-by":"publisher","first-page":"e12723","DOI":"10.1111\/hel.12723","volume":"25","author":"A Hwong-Ruey Leow","year":"2020","unstructured":"Hwong-Ruey Leow A, Chang JV, Goh KL. Searching for an optimal therapy for H pylori eradication: High-dose proton-pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days. Helicobacter. 2020;25(5):e12723.","journal-title":"Helicobacter."},{"issue":"3","key":"3692_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3892\/etm.2022.11153","volume":"23","author":"J Dai","year":"2022","unstructured":"Dai J, Zhao J, Mao L, Hu Y, Lv B. Study on the value of antibiotic-resistant gene detection in Helicobacter pylori in China. Exp Ther Med. 2022;23(3):228.","journal-title":"Exp Ther Med"},{"issue":"1","key":"3692_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1096\/fj.201900774R","volume":"34","author":"A Chu","year":"2020","unstructured":"Chu A, Wang D, Guo Q, Lv Z, Yuan Y, Gong Y. Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis. Faseb j. 2020;34(1):610\u20138.","journal-title":"Faseb j."},{"issue":"6","key":"3692_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101541","volume":"29","author":"F Maiorana","year":"2024","unstructured":"Maiorana F, Neschuk M, Caronia MV, Elizondo K, Schneider A, Veron G, et al. Helicobacter pylori cagA\/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease. Ann Hepatol. 2024;29(6): 101541.","journal-title":"Ann Hepatol"},{"key":"3692_CR19","doi-asserted-by":"crossref","unstructured":"Saracino IM, Fiorini G, Zullo A, Pavoni M, Saccomanno L, Vaira D. Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019. Antibiotics (Basel). 2020;9(1):26.","DOI":"10.3390\/antibiotics9010026"},{"issue":"1","key":"3692_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.gastro.2021.03.045","volume":"161","author":"KG Hulten","year":"2021","unstructured":"Hulten KG, Lamberth LB, Kalfus IN, Graham DY. National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial. Gastroenterology. 2021;161(1):342-4.e1.","journal-title":"Gastroenterology"},{"issue":"4","key":"3692_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1590\/s0004-2803.201900000-72","volume":"56","author":"C Parra-Sep\u00falveda","year":"2019","unstructured":"Parra-Sep\u00falveda C, Merino JS, S\u00e1ez-Carrillo K, Gonz\u00e1lez C, Garc\u00eda-Cancino A. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOB\u00cdO REGION (CHILE) IN A DECADE. Arq Gastroenterol. 2019;56(4):361\u20136.","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"3692_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12804","volume":"26","author":"SY Li","year":"2021","unstructured":"Li SY, Li J, Dong XH, Teng GG, Zhang W, Cheng H, et al. The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing. Helicobacter. 2021;26(4): e12804.","journal-title":"Helicobacter"},{"key":"3692_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.857569","volume":"13","author":"Y Choe","year":"2022","unstructured":"Choe Y, Kim JS, Choi HH, Kim DB, Park JM, Oh JH, et al. The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication. Front Microbiol. 2022;13: 857569.","journal-title":"Front Microbiol"},{"issue":"4","key":"3692_CR24","doi-asserted-by":"publisher","first-page":"e12698","DOI":"10.1111\/hel.12698","volume":"25","author":"R Horie","year":"2020","unstructured":"Horie R, Handa O, Ando T, Ose T, Murakami T, Suzuki N, et al. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan. Helicobacter. 2020;25(4):e12698.","journal-title":"Helicobacter"},{"issue":"6","key":"3692_CR25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1053\/j.gastro.2021.02.057","volume":"160","author":"DY Graham","year":"2021","unstructured":"Graham DY. Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time. Gastroenterology. 2021;160(6):1936\u20137.","journal-title":"Gastroenterology"},{"issue":"5","key":"3692_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00550-23","volume":"11","author":"M Xiong","year":"2023","unstructured":"Xiong M, Mohammed Aljaberi HS, Khalid Ansari N, Sun Y, Yin S, Nasifu L, et al. Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study. Microbiol Spectr. 2023;11(5): e0055023.","journal-title":"Microbiol Spectr"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03692-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:39:47Z","timestamp":1740062387000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03692-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of The First People's Hospital of Lianyungang (KY-20221205003\u201302). Written informed consent was obtained from all the participants or legal guardians of any participant under the age of 18 prior to the enrolment of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Written informed consent for publication of identifying images or other personal or clinical details was obtained from all the participants or legal guardians of any participant under the age of 18.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"96"}}